SOLV Solventum Earnings and EPS analysis

Relative Growth: Rel. Growth: 61

Relative Strength: Rel. Strength: 77

Relative Valuation: Rel. Valuation: 94

Relative Profitability: Rel. Profitability: 90

EPS in 2026 (TTM): $8.22

Last Report Period Date: Jun 30, 2026

Currently, SOLV's 12-month EPS stands at $8.22, according to the most recent financial reports. During 2025, SOLV reported a per-share earnings of $8.94, which shows a rise compared to the EPS of $2.77 recorded in 2024. SOLV recorded an EPS of $0.53 for the quarterly period ending on Jun 30, 2026.

SOLV earnings history

Historical annual and quarterly earnings per share (EPS) data for Solventum

EPS (TTM)

$8.22

EPS Growth YoY (Quarterly)

1.9%

EPS (Quarterly)

$0.53

EPS Growth (Quarterly)

657.1%

In 2025, Solventum's earnings per share was $8.94, a rise of 222.7% from $2.77 in 2024. Over the quarter ending Jun 30, 2026, the earnings per share came in at $0.53, reflecting a 1.9% increase compared to the same quarter a year earlier. As of June 2026, the TTM EPS is $8.22. During 2024, the annual earnings per share was $2.77, representing a decrease of 64.4% compared to 2023.

SOLV EPS vs price chart

SOLV EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

1.9%

EPS growth YoY

222.7%

EPS growth 3Y avg

4.7%

EPS growth 5Y avg

N/A

Solventum has recorded a growth in earnings per share of 1.9% in the past 12 months (YoY, quarterly). During the past three years, SOLV registered an average yearly EPS growth of 4.7%.

SOLV Earnings Waterfall

Breakdown of revenue, profit and net income for Solventum

SOLV Earnings vs Peers

What are the earnings of SOLV compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
SOLV Solventum Corp	10.75	222.7%	4.7%	N/A
OMCL Omnicell Inc	38.81	-85.2%	-32.5%	-44.5%
VEEV Veeva Systems Inc - Class A	43.6	25.9%	20.9%	17.1%
TDOC Teladoc Health Inc	N/A	80.6%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.